The Carbomedics Top Hat supraannular aortic valve: A multicenter study

Annals of Thoracic Surgery

Volumn 75, Issue 4, 2003, Pages 1175-1180

  Gillinov, A Marc ^a   Blackstone, Eugene H ^b   Alster, Joan M ^b   Craver, Joseph M ^b   Baumgartner, William A ^b   Brewster, Scot A ^b   Kleinman, Leonard H ^b   Smedira, Nicholas G ^b  

^a LERNER RESEARCH INSTITUTE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AORTA ROOT; AORTA SINUS; AORTA VALVE; AORTA VALVE REPLACEMENT; ARTICLE; BIOAVAILABILITY; BLEEDING; CONTROLLED STUDY; DEATH; FEMALE; FOLLOW UP; HEART EJECTION FRACTION; HEART VALVE; HUMAN; IMPLANTATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTHESIS; RISK FACTOR; STANDARD; SURGICAL TECHNIQUE; THROMBOEMBOLISM;

AORTIC VALVE; FEMALE; FOLLOW-UP STUDIES; HEART VALVE PROSTHESIS; HEMORRHAGE; HUMANS; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PROSTHESIS DESIGN; REOPERATION; SURVIVAL RATE; THROMBOEMBOLISM;

EID: 0037385525     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-4975(02)03991-7     Document Type: Article

References (17)

1. Copeland JG. The CarboMedics prosthetic heart valve: a second generation bileaflet prosthesis. Sem Thorac Cardiovasc Surg 1996;8:237-41.
2. Li HH, Hahn J, Urbanski P, Torka M, Grunkemeier GL, Hacker RW. Intermediate-term results with 1,019 Carbomedics aortic valves. Ann Thorac Surg 2001;71:1181-8.
3. Craver J. CarboMedics prosthetic heart valve. Eur J Cardiothorac Surg 1999;15:S3-11.
4. Fiane AE, Geiran OR, Svennevig JL. Up to eight years' follow-up of 997 patients receiving the CarboMedics prosthetic heart valve. Ann Thorac Surg 1998;66:443-8.
5. Fiane AE, Saatvedt K, Svennevig JL, Geiran O, Nordstrand K, Frøysaker T. The CarboMedics valve: midterm follow-up with analysis of risk factors. Ann Thorac Surg 1995;60:1053-8.
6. Bernal JM, Rabasa JM, Gutierrez-Garcia F, Morales C, Nistal F, Revuelta JM. The CarboMedics valve: experience with 1049 implants. Ann Thorac Surg 1998;65:137-43.
7. Dalrymple-Hay MJ, Pearce RK, Dawkins S, et al. Mid-term results with 1,503 CarboMedics mechanical valve implants. J Heart Valve Dis 2000;9:389-95.
8. Edmunds LH, Clark RE, Cohn LH, Grunkemeier GL, Miller DC, Weisel RD. Guidelines for reporting morbidity and mortality after cardiac valvular operations. J Thorac Cardiovasc Surg 1996;112:708-11.
9. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-81.
10. Blackstone EH, Naftel DC, Turner ME Jr. The decomposition of time-varying hazard into phases, each incorporating a separate stream of concomitant information. J Am Stat Assoc 1986;81:615-24.
11. Grunkemeier GL, Anderson WN Jr. Clinical evaluation and analysis of heart valve substitutes. J Heart Valve Dis 1998;7:163-9.
12. Breiman L. Bagging predictors. Machine Learning 1996;26:123-40.
13. Blackstone EH. Breaking down barriers: helpful breakthrough statistical methods you need to understand better. J Thorac Cardiovasc Surg 2001;122:430-9.
14. Lundblad R, Hagen OM, Smith G, Kvernebo K. The CarboMedics supraanular Top Hat valve improves prosthesis size in the aortic root. J Heart Valve Dis 2001;10:196-201.
15. Khan S, Chaux A, Matloff J, et al. The St. Jude Medical valve. Experience with 1000 cases. J Thorac Cardiovasc Surg 1994;108:1010-20.
16. Stein PD, Alpert JS, Horstkotte D, Turpie AG. Antithromboric therapy in patients with mechanical and biological prosthetic heart valves. Chest 1998;114:S602-10.
17. Horstkotte D, Schulte HD, Bircks W, Strauer BE. Lower intensity anticoagulation therapy results in lower complication rates with the St. Jude Medical prosthesis. J Thorac Cardiovasc Surg 1994;107:1136-45.